Accumulating evidence on the effect of the time of eating in relation to our circadian rhythm and metabolism shows that when we eat may influence our overall health and well-being.
Eli Lilly touts PhIII mirikizumab win in Crohn’s despite woes in other conditions
Eli Lilly said its anti-inflammatory medicine mirikizumab helped about half of people with Crohn’s disease enter remission after one year in a Phase III study.
October 13, 2023